Clinical Trial Update: Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating short-term Copaxone therapy for anti-inflammatory effects in acute decompensated heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytokine Storm
• Decompensated Heart Failure
• Heart Failure
• Inflammatory Response

Drugs mentioned

• COPAXONE (GLATIRAMER ACETATE)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Acute Decompensated Heart Failure, Cytokine Storm | Phase 2 | Status: COMPLETED